Maximizing the Gift of Tissue Donation

RegenTX Partners, LLC, San Antonio

RegenTX is a state of the art, AATB accredited human tissue processing company. Maximizing the usage and yield of donated tissue is the primary focus for us when it comes to tissue engineering, research and processing.

At RegenTX, we’re dedicated to advancing the clinical applications of tissue donation. Our mission is to support a range of medical conditions, from orthopedic injuries, aesthetics or reconstruction
surgeries to complex wound healing.

We use systematic research and advanced techniques to maintain tissue integrity, treating each donation with care and respect. Our goal is to amplify the impact of every donation, offering hope and healing to those in need. With a team of experts in tissue engineering and processing, we’re aiming to make a tangible difference in people’s lives.

At RegenTX, we see ourselves as stewards of tissue donation, dedicated to advancing its clinical applications while ensuring safety and adhering to all applicable regulatory guidelines.

What We Do

At RegenTX, we process donated tissues at our state-of-the-art facility, using carefully designed methods to maintain tissue quality and integrity. Our internal tissue engineering and research team is constantly trying to improve processing yield, generate scientific data and expand the usage of the donated tissue into more therapeutic applications.

Donated Tissues

Donated tissues have a profound impact on medical treatments and patient outcomes. They are used in a variety of surgical procedures, including reconstructive surgeries, burn treatment, ligament and tendon repair, the treatment of non-healing wounds, and heart valve replacement. Corneas from donors can restore sight to individuals with corneal blindness. Each donated tissue not only enhances the quality of life for recipients but also provides a lasting legacy of generosity and compassion from the donor.

Birth Tissue

The Uniqueness of Amniotic Membrane

The development of human birth tissue allografts of the highest quality has always been at the forefront of RegenTX’s mission. Birth tissue has unique properties that may help to stimulate the body’s own healing. It possesses valuable biophysical and biochemical characteristics that may modulate various cell functions, which, on the other hand, may support wound healing, and vascularization. Birth tissue may also act as a highly biocompatible natural scaffold and is described in the literature as a material rich of several types of stem cells, growth factors, and cytokines.

Our expertise in human placental tissues, from amniotic membrane to full thickness placental membrane, is rooted in a deep scientific understanding. Today, RegenTX offers a wide range of human placental tissue products.

Adipose Tissue

A Natural Option To
Advance Patient Care

Adipose tissue allografts have the potential to advance patient care with an easily accessible, natural option in contrast to an expensive autologous fat transfer procedure. Additionally, recent research has further characterized adipose tissue as a complex and highly active endocrine organ.

Our ongoing research program concentrates on innovating the potential of adipose tissue as a regulatory-compliant structural allograft that supports the patient’s own adipose tissues. This program has already identified several technologies critical for the safe, effective, and responsible processing of adipose tissue.

Dermal Allografts

Accelerating Tissue Innovations

At RegenTX, we accelerate tissue innovations of recognized treatments, which include dermal allografts. Dermis is the first line of deeper anatomical structures. It is a commonly used allograft for protection of skin wound treatment. As dermis is a dense network of tough, elastic collagen fibers, minimal manipulation of the allograft is crucial to secure its function as a barrier.

The purpose of our dermal tissue-based allografts research program is to modernize the processing methods to produce an effective and compliant allograft. It is expected to be launched in 2026.

 

How to find us